1. Amustaline (S‐303) treatment inactivates high levels of Zika virus in red blood cell components. Issue 3 (5th February 2017) Authors: Laughhunn, Andrew; Santa Maria, Felicia; Broult, Julien; Lanteri, Marion C.; Stassinopoulos, Adonis; Musso, Didier; Aubry, Maite Journal: Transfusion Issue: Volume 57:Issue 3(2017)Part 2 Page Start: 779 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inactivation of yellow fever virus with amotosalen and ultraviolet A light pathogen‐reduction technology. Issue 3 (20th January 2020) Authors: Girard, Yvette A.; Santa Maria, Felicia; Lanteri, Marion C. Journal: Transfusion Issue: Volume 60:Issue 3(2020) Page Start: 622 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination. Issue 8 (3rd July 2017) Authors: Santa Maria, Felicia; Laughhunn, Andrew; Lanteri, Marion C.; Aubry, Maite; Musso, Didier; Stassinopoulos, Adonis Journal: Transfusion Issue: Volume 57:Issue 8(2017) Page Start: 2016 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pathogen inactivation of Dengue virus in red blood cells using amustaline and glutathione. Issue 12 (16th September 2017) Authors: Aubry, Maite; Laughhunn, Andrew; Santa Maria, Felicia; Lanteri, Marion C.; Stassinopoulos, Adonis; Musso, Didier Journal: Transfusion Issue: Volume 57:Issue 12(2017) Page Start: 2888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗